Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 1 of 51, showing 5 Applications out of 255 total, starting on record 1, ending on 5

# Protocol No Study Title Investigator(s) & Site(s) Application Status

1.

ECCT/20/11/01   GC vaccine study in kenya
    Protocol Title: USE OF BEXSERO IMMUNIZATION TO DETECT CROSS REACTIVE ANTIGENS AND ANTI-GONOCOCCAL ANTIBODIES IN KEY POPULATIONS IN KENYA.   
Principal Investigator(s)
1. Prof. Eduard Sanders
Site(s) in Kenya
The KEMRI-Wellcome Trust Research Programme (KWTRP) Kenya Medical Research Institute (KEMRI) / Wellcome Trust Centre for Geographic Medicine Research – Coast (CGMRC)
 
Trial Status (not set!)
Protocol Date 21-07-2020
View

2.

ECCT/20/11/03   IMR-SCD-301
    A Phase 2b Study to Evaluate the Safety and Efficacy of IMR-687 in Subjects with Sickle Cell Disease       
Principal Investigator(s)
1. Jessie Nyokabi Githanga
2. Videlis Nduba
Site(s) in Kenya
1. Kenya Medical Research Institute-Kondele Children\'s Hospital (Kisumu county)
2. The Center For Respiratory Disease Research/KEMRI (Nairobi City county)
3. Gertrude\'s Children\'s Hospital (Nairobi City county)
 
Trial Status (not set!)
Protocol Date 29-01-2020
View

3.

ECCT/20/10/03   Commercial Typhoid tests valid
    Comparative study of commercially available typhoid point of care tests to benchmark current and emerging tools   
Principal Investigator(s)
1. Robert Sanaya Onsare
Site(s) in Kenya
1. Mbagathi County Hospital (Nairobi City county)
2. Medical Missionaries of Mary, Reuben Centre Hospital, Mukuru (Nairobi City county)
3. City Council Clinic, Mukuru (Nairobi City county)
 
Trial Status (not set!)
Protocol Date 11-08-2020
View

4.

ECCT/20/10/04   yellow fever vaccine CVIA 079
    A Phase III double-blind, randomized, active comparator controlled study in healthy Kenyan adolescents, young children and infants to assess the safety and immunogenicity of Beijing Institute of Biologic Products (BIBP) yellow fever vaccine in comparison to a WHO 17D-204 prequalified comparator yellow fever vaccine, as well as lot-to-lot consistency of immune response to the BIBP yellow fever vaccine”, CVIA 079.   
Principal Investigator(s)
1. Dr. Deborah Langat
Site(s) in Kenya
KEMRI/KERICHO CLINIC RESEARCH CENTRE
 
Trial Status (not set!)
Protocol Date 16-09-2020
View

5.

ECCT/20/09/06   Schisto RDT evaluation
    A performance evaluation of a prototype rapid diagnostic test for the diagnosis of schistosomiasis   
Principal Investigator(s)
1. Sammy Njenga
Site(s) in Kenya
Kenya Medical Research Institute (KEMRI)
 
Trial Status (not set!)
Protocol Date 14-08-2020
View